C. Kollmannsberger

Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma

Helmut Dittmann, Martin Sökler, C. Kollmannsberger et al. · Oncology Reports · 2001 · 73 citations

Medicine, Oncology, Radiology +14

Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma

C. Kollmannsberger, Wolfram Brugger, Jörg T. Hartmann et al. · Anti-Cancer Drugs · 1999 · 40 citations

Medicine, Oncology, Pharmacology +17

Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)

C. Kollmannsberger, Hal W. Hirte, Lillian L. Siu et al. · Annals of Oncology · 2011 · 39 citations · Full text

Medicine, Oncology, Pharmacology +9

Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer

M. Kuczyk, C. Bokemeyer, Julia Hartmann et al. · Oncology Reports · 2001 · 34 citations

Medicine, Molecular Genetics, Oncology +14

Activity of cediranib (AZD2171) in patients (pts) with previously untreated metastatic renal cell cancer (RCC). A phase II trial of the PMH Consortium

Srikala S. Sridhar, Mary J. MacKenzie, Sebastién J. Hotte et al. · Journal of Clinical Oncology · 2008 · 34 citations

Medicine, Oncology, Pharmacology +16